Cleveland Clinic 25th Annual Diabetes Therapeutics, Technology and Surgery 2021
Overview
18 videos + 19 pdfs, size: 1.04 GB
Information:
Overview
The 25th annual Diabetes Day: Therapeutics, Technology and Surgery is presented by the Cleveland Clinic Department of Endocrinology, Diabetes and Metabolism to provide up-to-date reviews of management strategies and research on the complications of diabetes. Key topic areas that will be addressed include:
For over twenty five years, Cleveland Clinic has been at the forefront of diabetes treatment, research and education. Its world class faculty has designed Diabetes Therapeutics, Technology and Surgery to provide up-to-date reviews of management strategies and research on the complications of this disease. It includes a detailed analysis of therapeutic options applicable to type 1 and type 2 diabetes, as well as their complications
Diabetes Day, Therapeutics, Technology and Surgery, is presented by the Cleveland Clinic Department of Endocrinology, Diabetes and Metabolism to provide up-to-date reviews of management strategies and research on the complications of diabetes. Key topic areas that will be addressed include a review of therapeutic options to manage both type 1 and 2 diabetes and the complications, including a pump update, dual hormone therapies, sulfonylureas, GLP1 agonists, metformin, and the role of exercise and fasting. New this year is a discussion of the pathophysiologic impact of COVID-19. The goal of this course is to increase practitioners’ competence and clinical performance to treat diabetes and its complications and, ultimately, to improve patient outcomes.
Attendees will be able to:
- Describe the efficacy and side effects of therapeutic innovations for type 1 diabetes, including closed-loop insulin pumps, dual hormone therapy, and glucagon.
- Compare the effectiveness of new and emerging therapies for both type 1 and 2 diabetes.
- Critically appraise the impact of bariatric surgery on patients with type 2 diabetes.
- Describe options for treating children with type 2 diabetes.
- Compare the data on effectiveness of diets and exercise in diabetes strategies.
- Summarize research defining the pathophysiologic impact of nonalcoholic steatohepatitis.
- Describe how COVID-19 affects the progression of diabetes in infected patients
Who should attend?
This activity is designed for primary care physicians, endocrinologists, diabetes educators, pharmacists, nurses, nurse practitioners, physician assistants, and other health care professionals who care for patients with diabetes.
List of Topics:
Are Sulfonyureas Safe Focus on Carolina Trial.mp4
Are Sulfonyureas Safe Focus on Carolina Trial.pdf
Cardiovascular Outcomes of Bariatric Surgery in Patients with Obesity and Diabetes.mp4
Cardiovascular Outcomes of Bariatric Surgery in Patients with Obesity and Diabetes.pdf
Dawn of Glucagon.mp4
Dawn of Glucagon.pdf
Diabetes and Lipids What Do the Guidelines Say.mp4
Diabetes and Lipids What Do the Guidelines Say.pdf
Diabetes Management in Patients with COVID-19.mp4
Diabetes Management in Patients with COVID-19.pdf
Do It Yourself (DIY).mp4
Do It Yourself (DIY).pdf
Dual Hormone.mp4
Dual Hormone.pdf
GLP-1 Agonists – Oral VS. SubQ.pdf
Intermittent Fasting.mp4
Intermittent Fasting.pdf
Management of Hypoglycemia Post Gastric Bypass.mp4
Management of Hypoglycemia Post Gastric Bypass.pdf
Metformin Mechanism of Action – Role of Peptide YY, GLP-1 and GDF-15.mp4
Metformin Mechanism of Action – Role of Peptide YY, GLP-1 and GDF-15.pdf
New Insulins.mp4
New Insulins.pdf
New Treatment Options for Diabetes and the Kidney.mp4
New Treatment Options for Diabetes and the Kidney.pdf
Pump Update-Hybrid Closed Loop (Control IQ, 780G, Horizon).mp4
Pump Update-Hybrid Closed Loop (Control IQ, 780G, Horizon).pdf
Role of Exercise in Management of Diabetes.mp4
Role of Exercise in Management of Diabetes.pdf
Should Metformin be First Line Therapy in Patients with DM2 and CAD.mp4
Should Metformin be First Line Therapy in Patients with DM2 and CAD.pdf
Should NASH be Considered Part of the Metabolic Syndrome.mp4
Should NASH be Considered Part of the Metabolic Syndrome.pdf
Surgical Management of Gastroparesis POP vs Pyloroplasty.mp4
Surgical Management of Gastroparesis POP vs Pyloroplasty.pdf
Treatment of Type 2 Diabetes in Children.mp4
Treatment of Type 2 Diabetes in Children.pdf